Company Activities Contact Intranet Press Physicians Patients Families Veterinarians News & events Careers Results online Pay
en
EN FR DE

Cardiovascular health

Home Lab tests Analyses by indications Cardiovascular health
PLAC Test
Determination of the stroke and heart attack risk

Innovative blood test to determine the individual risk of stroke and heart attack

The PLAC® test is an innovative risk marker that measures the enzymatic activity of Lp-PLA2 (lipoprotein-associated phospholipase A2), a specific biomarker for vascular inflammation involved in the formation of unstable plaques that cause majority of cardiovascular events. 

This easy blood test for the detec­tion of Lp-PLA2 offers a more individual risk assess­ment than the usual examinations. Approximately 70% of the heart attacks and most of the strokes are caused by rupture of vascular de­posits, also called atherosclerotic plaques.

Who should be tested and when?

Men ≥ 45; women ≥ 55 with at least 2 of these risk factors:

  • Hypertension
  • History of cardiovascular diseases or diabetes
  • Overweight
  • Increased cholesterol levels
  • Smoking
  • Lack of exercise

Results and Interpretation

The determination of Lp-PLA2 (a vessel-specific inflammation enzyme) shows if plaques are located within the arte­rial vessel wall that tend to rupture. The PLAC®-Test results allow to stratify the individual risk of a patient and ad­just the treatment depending on the results.

Additional information:

The PLAC®-Test is a CE-labelled test.

 

Read more…